Cargando…
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
High-risk human papillomavirus (HPV) are responsible for genital and oral cancers associated with the expression of the E6/E7 HPV oncogenes. Therapeutic vaccines targeting those oncogenes can only partially control tumor progression, highlighting the necessity to investigate different treatment stra...
Autores principales: | Domingos-Pereira, Sonia, Galliverti, Gabriele, Hanahan, Douglas, Nardelli-Haefliger, Denise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503370/ https://www.ncbi.nlm.nih.gov/pubmed/31060612 http://dx.doi.org/10.1186/s40425-019-0593-1 |
Ejemplares similares
-
Intravaginal TLR agonists increase local vaccine-specific CD8 T-cells and human papillomavirus-associated genital-tumor regression in mice
por: Domingos-Pereira, Sonia, et al.
Publicado: (2012) -
Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells
por: Decrausaz, Loane, et al.
Publicado: (2013) -
Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model
por: Domingos-Pereira, Sonia, et al.
Publicado: (2021) -
What is the influence of vaccination’s routes on the regression of tumors located at mucosal sites?
por: Nardelli-Haefliger, Denise, et al.
Publicado: (2012) -
hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis
por: de Wilde, Jillian, et al.
Publicado: (2010)